Clinical Trials Browser

Phase 3 × INDUSTRY × Melanoma × Clear all

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Neoplasm Metastasis, Neoplasms, Skin Diseases, Skin Neoplasms

Melanoma, Nevus, Blue

Uveal Melanoma, Melanoma

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

Melanoma, Neoplasm Metastasis

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

Melanoma, Neoplasm Metastasis

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

Brain Neoplasms, Melanoma

Melanoma, Skin Neoplasms

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma

Melanoma, Skin Neoplasms

Fever, Melanoma

Melanoma, Skin Neoplasms

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

Melanoma, Neoplasms

Melanoma, Neoplasms

Melanoma, Skin Neoplasms

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasm Metastasis, Skin Neoplasms

Clinical Trials

CheckMate76K

A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma

MK-3475-054

COLUMBUS

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Neoadjuvant Darovasertib in Primary Uveal Melanoma

LEAP-003

Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma

A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

RELATIVITY-098

LEAP-003

Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma

NeoDREAM

MAVIS

KEYVIBE-010

Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

V940-001

COMBI-i

IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)

RELATIVITY-127

OH2 Injection in Melanoma

Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma

A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

NEO-MIMAJOR

UNIVERSE

Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

COMBI-APlus

CheckMate 238

A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma

CheckMate-6GE

OCTAVA

KEYNOTE-716

Pivotal

Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma

Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma

COLUMBUS-AD

Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma

COMBI-AD

PIVOT-12

FLAT

MASTERKEY-265

A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma

CheckMate 066